Payment overview · 2025
General Payments
$399.38
3 reported records · 2 companies
Healthcare provider profile · identity verified
Ankur N Patel, MD
Allopathic & Osteopathic Physicians|Internal Medicine · WAUWATOSA, WI · NPI 1043327372
Verified facts
What the public records show
CMS Open Payments records show Ankur N Patel, MD received $399.38 in general payments during 2025 across 3 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 62.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $250.00 | 62.6% | 2 | 2025 |
| ZOLL Respicardia, Inc. | Unresolved — no canonical attribution shown | $149.38 | 37.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $399.38 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $250.00 | 2 | 2025 |
Source payment records
|
|||||
| remede System Normalized: remede system |
Device | ZOLL Respicardia, Inc. | $149.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 901 | 245 |
| Amlodipine Besylate | Amlodipine Besylate | 714 | 205 |
| Gabapentin | Gabapentin | 399 | 104 |
| Metoprolol Succinate | Metoprolol Succinate | 340 | 88 |
| Tamsulosin Hcl | Tamsulosin Hcl | 335 | 91 |
| Levothyroxine Sodium | Levothyroxine Sodium | 308 | 78 |
| Losartan Potassium | Losartan Potassium | 282 | 85 |
| Pantoprazole Sodium | Pantoprazole Sodium | 271 | 82 |
| Lisinopril | Lisinopril | 263 | 67 |
| Omeprazole | Omeprazole | 260 | 77 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 257 | 67 |
| Metformin Hcl Er | Metformin Hcl | 207 | 51 |
| Simvastatin | Simvastatin | 202 | 59 |
| Furosemide | Furosemide | 197 | 62 |
| Allopurinol | Allopurinol | 196 | 45 |
| Jardiance | Empagliflozin | 180 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 169 | 32 |
| Metformin Hcl | Metformin Hcl | 162 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 159 | 48 |
| Eliquis | Apixaban | 150 | 23 |
| Celecoxib | Celecoxib | 146 | 49 |
| Glimepiride | Glimepiride | 146 | 37 |
| Valsartan | Valsartan | 141 | 48 |
| Tizanidine Hcl | Tizanidine Hcl | 131 | 45 |
| Trazodone Hcl | Trazodone Hcl | 131 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 128 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 126 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 125 | 33 |
| Carvedilol | Carvedilol | 120 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 114 | 40 |
| Mirtazapine | Mirtazapine | 113 | 28 |
| Montelukast Sodium | Montelukast Sodium | 112 | 29 |
| Potassium Chloride | Potassium Chloride | 110 | 35 |
| Tramadol Hcl | Tramadol Hcl | 101 | 17 |
| Clonazepam | Clonazepam | 96 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 95 | 24 |
| Zolpidem Tartrate | Zolpidem Tartrate | 95 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 94 | 22 |
| Spironolactone | Spironolactone | 93 | 29 |
| Famotidine | Famotidine | 92 | 21 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 91 | 28 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 88 | 28 |
| Lorazepam | Lorazepam | 82 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 80 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 79 | 25 |
| Alprazolam | Alprazolam | 75 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 68 | 26 |
| Finasteride | Finasteride | 67 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 67 | 23 |
| Sertraline Hcl | Sertraline Hcl | 67 | 18 |
| Ezetimibe | Ezetimibe | 66 | 18 |
| Prednisone | Prednisone | 65 | 50 |
| Meclizine Hcl | Meclizine Hcl | 64 | 22 |
| Pregabalin | Pregabalin | 63 | suppressed |
| Januvia | Sitagliptin Phosphate | 61 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 60 | 24 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 59 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 22 |
| Linzess | Linaclotide | 55 | 19 |
| Donepezil Hcl | Donepezil Hcl | 53 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 22 |
| Baclofen | Baclofen | 50 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 50 | 14 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 49 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 47 | suppressed |
| Metolazone | Metolazone | 47 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 43 | suppressed |
| Xarelto | Rivaroxaban | 42 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 40 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 39 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 38 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | 12 |
| Ibandronate Sodium | Ibandronate Sodium | 38 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 38 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 36 | 12 |
| Solifenacin Succinate | Solifenacin Succinate | 35 | 13 |
| Trulicity | Dulaglutide | 35 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 35 | 12 |
| Lovastatin | Lovastatin | 34 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 33 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 33 | suppressed |
| Myrbetriq | Mirabegron | 33 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Meloxicam | Meloxicam | 32 | 11 |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Glipizide | Glipizide | 31 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 31 | suppressed |
| Atenolol | Atenolol | 30 | suppressed |
| Levetiracetam | Levetiracetam | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | suppressed |
| Irbesartan | Irbesartan | 28 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 27 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 27 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 15 |
| Entresto | Sacubitril/Valsartan | 25 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Telmisartan | Telmisartan | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Olanzapine | Olanzapine | 24 | suppressed |
| Ramelteon | Ramelteon | 24 | suppressed |
| Acyclovir | Acyclovir | 23 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Brilinta | Ticagrelor | 19 | suppressed |
| Diazepam | Diazepam | 19 | suppressed |
| Dutasteride | Dutasteride | 19 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | 11 |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 12 |
| Torsemide | Torsemide | 16 | suppressed |
| Tradjenta | Linagliptin | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | 13 |
| Divalproex Sodium | Divalproex Sodium | 15 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 15 | suppressed |
| Ozempic | Semaglutide | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Nabumetone | Nabumetone | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Indapamide | Indapamide | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $399.38 · 3 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA, remede System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error